Shandong Provincial Hospital

Neurology

The Department of Neurology of Shandong Provincial Hospital adheres to the tenet of "building a department with quality, establishing a department with talents, and developing a department with science and education." After several generations of inheritance and efforts, the scale of the discipline has gradually grown, and it has made great progress in clinical, teaching, scientific research, talent training, and academic echelon construction. It has become a team with strong strength, famous doctors, and strong academic influence in the country. In 2022, it was awarded the title of "National Key Clinical Specialty" construction unit. At present, the department is the Key Laboratory of Endocrinology, Glucolipid Metabolism and Brain Aging of the Ministry of Education, the Chief Scientist Unit of the National Key R&D Program, Taishan Scholar Positions, a Ph.D. and Master's Awarding Point in Neurology, a Postdoctoral Training Base, a National Difficult and Critical Care Improvement Project (in the direction of cardiovascular and cerebrovascular diseases), a national training base for neurology backbone teachers for resident physician training, a national neurology training and training base, and a national neurology training base. Interventional training and training base, National Advanced Stroke Center, National Core Advanced Cognitive Impairment Diagnosis and Treatment Center, National Encephalitis Integrated Unit, National Level 3 Epilepsy Center, Shandong Provincial Clinical Medical Research Center for Neurological Diseases, Shandong Provincial Key Clinical Specialties, Shandong Provincial Key Laboratory of Medicine and Health, and the All-China Federation of Trade Unions "Worker Pioneer" unit. Its service capabilities and academic level are in the leading position in the province. It has been approved as the Shandong Branch of the National Clinical Research Center for Geriatric Diseases (Xuanwu Hospital), the Shandong Branch of the National Clinical Research Center for Neurological Diseases (Tiantan Hospital), and the first batch of core advanced cognitive impairment diagnosis and treatment centers of the National Health Commission Capacity Building and Continuing Education Center. In accordance with the hospital's discipline development plan, the department grasps the development elements of the discipline, rationally lays out the direction of discipline development, and formulates a discipline development strategy of "improving the ultimate diagnosis and treatment level", "building a talent echelon for the discipline" and "increasing academic influence". The department was one of the first in China to establish subspecialty teams with distinctive features, standardized operations, and strong influence in the country such as cerebrovascular disease, cognitive impairment and neurodegenerative diseases, Parkinson's disease and movement disorders, neuroimmune and infectious diseases, neuromuscular diseases, epilepsy and seizure disorders, sleep disorders and related diseases, neurological critical illness, and neurological rehabilitation. At the same time, the construction of the department is based on a high starting point, high standards, and high levels, with core new technologies as a breakthrough point. It has mastered many new technologies for the diagnosis and treatment of neurological problems and critical diseases, and has strong clinical diagnosis and treatment capabilities. At present, the department's "early multimodal intervention for Alzheimer's disease", "IVUS-assisted carotid artery stent implantation", "immune-targeted treatment of severe autoimmune encephalitis technology", "deep brain stimulation technology for the treatment of refractory epilepsy", "myoelectrically guided local injection of botulinum toxin type A for the treatment of dystonia" and "computer cognitive assessment and training advanced cognitive rehabilitation technology" and other technologies have reached the domestic leading level. In terms of scientific research and academics, teams in various sub-professional wards have carried out high-quality scientific research work, among which they have strong influence internationally in the fields of scientific research and innovation on Alzheimer's disease. The department has published 52 papers included in SCI, including top international magazines such as NATURE and PANS; it has undertaken more than 20 major projects including the US NIH and the National Natural Science Foundation of China, with a total scientific research funding of 10 million yuan. The department focuses on strengthening scientific research capabilities and focuses on the prevention and treatment of major diseases in the field of neurology in my country. It has carried out a series of scientific research that closely integrates clinical and basic research, and has achieved a series of results. It has strong comprehensive scientific research strength and innovation and transformation capabilities. The "Dementia and Cognitive Impairment Prevention and Treatment Research Group" of the department is committed to the early prevention and treatment of Alzheimer's disease. It has launched the "MIND-CHINA" cohort study and has become one of the five sub-centers of the Global Early Prevention and Treatment of Alzheimer's Disease Research ("World Wide FINGERS"). In recent years, the department has undertaken 3 major national scientific research projects, 1 key international cooperation project of the National Natural Science Foundation, 21 National Natural Science Foundation projects, and has undertaken 33 provincial and ministerial level scientific research projects as the first person in charge. More than 330 scientific research papers have been included in SCI magazines, including top international magazines such as Nature Communications, Alzheimer’s & Dementia, eBioMedicine, JAMA neurology, and Lancet Public Health.